We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Digital CZT Detectors Developed for Pre-clinical Imaging

By Biotechdaily staff writers
Posted on 11 Oct 2007
New digital cadmium zinc telluride (CZT) detectors for nuclear imaging applications have advantages over photomultiplier tube- (PMT)-based detectors, including that of increased sensitivity.

Gamma Medica-Ideas, Inc. More...
(GM-I; Oslo, Norway), a developer of digital medical imaging devices for the pre-clinical and clinical markets, has recently developed digital cadmium zinc telluride (CZT) detectors for nuclear imaging. The Oklahoma Medical Research Foundation (OMRF; Oklahoma City, OK, USA) installed the detectors in a dual-modality single photon emission tomography/computed tomography (SPECT/CT) configuration for pre-clinical imaging.

Dr. Rheal Towner, director of the MRI (Magnetic Resonance Imaging) Facility for the Free Radical Biology & Aging Research Program at OMRF, reported that GM-I's digital CZT detectors offer strong advantages over photomultiplier tube (PMT)-based detectors. "Gamma Medica-Ideas' state-of-the-art digital CZT detectors allow OMRF to benefit from increased sensitivity, which traditional PMT-based detectors cannot provide,” said Dr. Towner.

Oklahoma Medical Research Foundation's main research efforts are grouped into three major areas: cancer research, neurologic disease research, and cardiovascular disease research. Gamma Medica-Ideas' Flex system currently installed in OMRF's Small Animal Imaging Facility is used principally to look at metastases in animal cancer models, study metastases in lungs and design molecular targeted agents.

"Digital detection systems for nuclear medicine will soon make analog photomultiplier tube-based systems obsolete in the same way that digital mobile phones replaced analog cellular and digital technology has taken over analog in every audio/video market. It's more efficient, more reliable, and vastly better technology. With digital technology everything is better--performance, maintenance, and upgrading,” said Gamma Medica-Ideas president and CEO, Dr. Bradley Patt.

Gamma Medica-Ideas' Flex pre-clinical system, recently upgraded to the Flex Triumph multi-modality pre-clinical platform, provides multiple configurations to meet user needs. It can combine up to three different imaging modalities (PET [positron emission tomography], SPECT, and CT) in a single platform. Major application areas include cardiology, neurology, oncology, and bone analysis.


Related Links:
Gamma Medica-Ideas
Oklahoma Medical Research Foundation

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Automated Urinalysis Solution
UN-9000
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

Hereditary breast and ovarian cancer can be difficult to explain genetically, leaving many high-risk families without clear answers. Although 13 established risk genes, including BRCA1 and BRCA2, are routinely... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.